Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Alzheimer Disease

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Alzheimer Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hook, VY; Reisine, TD1
Ivy, GO1

Other Studies

2 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Alzheimer Disease

ArticleYear
Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
    Journal of neuroscience research, 2003, Nov-01, Volume: 74, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cells, Cultured; Chromaffin Cells; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dithiothreitol; Endopeptidases; Extracellular Space; Glutathione; Leucine; Mice; Mice, Knockout; Mutation; Neurons; Nicotine; Nicotinic Agonists; Peptide Fragments; Potassium Chloride; Secretory Vesicles; Substrate Specificity; Time Factors

2003
Protease inhibition causes some manifestations of aging and Alzheimer's disease in rodent and primate brain.
    Annals of the New York Academy of Sciences, 1992, Dec-31, Volume: 674

    Topics: Aging; Alzheimer Disease; Animals; Brain; Dolichols; Endopeptidases; Humans; Immunologic Techniques; Intermediate Filaments; Leucine; Leupeptins; Lipofuscin; Macaca fascicularis; Male; Protease Inhibitors; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Ubiquitins

1992